Trademark: 85249207
Status Date
Friday, April 1, 2022
Registration Number
4028548
Registration Date
Tuesday, September 20, 2011
Filing Date
Wednesday, February 23, 2011
Published for Opposition
Tuesday, July 5, 2011
Cancellation Date
Friday, April 1, 2022
42 conducting clinical trials; conducting clinical trials on the safety and effectiveness of azacitidine in connection with Acute Myeloid Leukemia, Myelodysplastic Syndromes, Lymphoma, Multiple Myeloma, Leukemia, and Myelomonocytic Chronic Leukemia
Apr 1, 2022
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Sep 20, 2020
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Dec 2, 2016
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Dec 2, 2016
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Dec 2, 2016
Case Assigned To Post Registration Paralegal
Sep 21, 2016
Teas Section 8 & 15 Received
Sep 20, 2016
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 29, 2015
Teas Change Of Correspondence Received
Sep 20, 2011
Registered-Principal Register
Jul 5, 2011
Official Gazette Publication Confirmation E-Mailed
Jul 5, 2011
Published For Opposition
May 26, 2011
Approved For Pub - Principal Register
May 25, 2011
Assigned To Examiner
Feb 26, 2011
New Application Office Supplied Data Entered In Tram
Feb 26, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
